T. Rowe Price Associates
PTRA

T. Rowe Price Associates’s Proterra Inc. Common Stock PTRA Stock Holding History

T. Rowe Price Associates’s Portfolio PTRA Stock Details PTRA Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2023
Q3 		– Sell
-102,308
Closed -$123K – 2942
2023
Q2 		$123K Sell
102,308
-9,100
-8% -$11.2K ﹤0.01% 2656
2023
Q1 		$170K Buy
111,408
+3,276
+3% +$12.3K ﹤0.01% 2565
2022
Q4 		$408K Sell
108,132
-5,549
-5% -$29.3K ﹤0.01% 2230
2022
Q3 		$567K Buy
113,681
+30,386
+36% +$170K ﹤0.01% 2062
2022
Q2 		$386K Buy
83,295
+25,595
+44% +$157K ﹤0.01% 2332
2022
Q1 		$434K Buy
57,700
+26,000
+82% +$211K ﹤0.01% 2399
2021
Q4 		$280K Buy
+31,700
New +$325K ﹤0.01% 2615

Other funds holding PTRA

TI
Tidal Investments Milwaukee, Wisconsin $47.4B AUM 59.58% 1-Year Est. Return
XT
XTX Topco George Town, Cayman Islands $5.75B AUM 30.56% 1-Year Est. Return
Public Employees Retirement Association of Colorado
Public Employees Retirement Association of Colorado Denver, Colorado $25.5B AUM 28.85% 1-Year Est. Return
BCWM
Bartlett & Co Wealth Management Cincinnati, Ohio $7.99B AUM 20.76% 1-Year Est. Return

T. Rowe Price Associates's PTRA Position: Q3 2023 in Review

T. Rowe Price Associates sold out of Proterra Inc. Common Stock (PTRA) in Q3 2023, closing a stake of 102,308 shares — an estimated $123K sold.

T. Rowe Price Associates first reported a position in PTRA in Q4 2021 and held it in 7 quarters. The position peaked at $567K in Q3 2022. 7 funds tracked by Wall St. Rank hold PTRA as of Q3 2023.

  • T. Rowe Price Associates reported no remaining Proterra Inc. Common Stock position as of Q3 2023 after selling out during the quarter.
  • T. Rowe Price Associates sold 102,308 Proterra Inc. Common Stock shares in Q3 2023, an estimated $123K.
  • T. Rowe Price Associates first reported a position in Proterra Inc. Common Stock in Q4 2021 and held it in 7 quarters.
  • T. Rowe Price Associates's Proterra Inc. Common Stock position peaked at $567K in Q3 2022.
  • 7 funds tracked by Wall St. Rank held Proterra Inc. Common Stock as of Q3 2023.

Based on T. Rowe Price Associates's 13F filing for Q3 2023, filed 14 Nov 2023.